自体造血干细胞移植治疗系统性硬化症。 - Suppr

Suppr

超能文献

Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation.

作者信息

Tyndall A, Black C, Finke J, Winkler J, Mertlesmann R, Peter H H, Gratwohl A

出版信息

Lancet. 1997 Jan 25;349(9047):254. doi: 10.1016/s0140-6736(05)64864-7.

DOI:10.1016/s0140-6736(05)64864-7

PMID:9014919

Abstract

摘要

相似文献

Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation.自体造血干细胞移植治疗系统性硬化症。

Lancet. 1997 Jan 25;349(9047):254. doi: 10.1016/s0140-6736(05)64864-7.

Autologous stem-cell transplantation in refractory autoimmune diseases after in vivo immunoablation and ex vivo depletion of mononuclear cells.体内免疫消融和体外单核细胞清除后难治性自身免疫性疾病的自体干细胞移植。

Arthritis Res. 2000;2(4):327-36. doi: 10.1186/ar107. Epub 2000 Jun 8.

Autologous haemopoietic stem cell transplantation.自体造血干细胞移植

Lancet. 1997 Mar 22;349(9055):881. doi: 10.1016/S0140-6736(05)61788-6.

Second autologous haematopoietic stem cell transplantation in systemic sclerosis-a case report.系统性硬化症的第二次自体造血干细胞移植——病例报告

Rheumatology (Oxford). 2019 Jul 1;58(7):1305-1307. doi: 10.1093/rheumatology/kez010.

Autologous hematopoietic cell transplantation for systemic sclerosis - a challenge for the Canadian health care system.系统性硬化症的自体造血细胞移植——加拿大医疗保健系统面临的一项挑战。

CMAJ. 2017 May 1;189(17):E623-E624. doi: 10.1503/cmaj.161346.

Autologous hematopoietic stem cell transplantation in systemic sclerosis: A reset to tolerance?自身造血干细胞移植治疗系统性硬化症：重置耐受？

Immunol Lett. 2018 Mar;195:88-96. doi: 10.1016/j.imlet.2017.11.005. Epub 2017 Nov 16.

Scattered pustular lesions 10 days after Shingrix vaccination in systemic sclerosis patient after successful autologous non-myeloablative haemopoietic stem-cell transplantation.在自体非清髓性造血干细胞移植成功后的系统性硬化症患者中，接种Shingrix疫苗10天后出现散在脓疱性病变。

BMJ Case Rep. 2024 Jul 10;17(7):e259620. doi: 10.1136/bcr-2024-259620.

Marked and sustained improvement 2 years after autologous stem cell transplantation in a girl with systemic sclerosis.一名系统性硬化症女孩自体干细胞移植两年后取得显著且持续的改善。

Rheumatology (Oxford). 1999 Aug;38(8):773. doi: 10.1093/rheumatology/38.8.773.

Autologous stem cell transplantation in scleroderma.硬皮病的自体干细胞移植。

Presse Med. 2021 Apr;50(1):104065. doi: 10.1016/j.lpm.2021.104065. Epub 2021 Feb 3.

Acquired haemophilia A in a patient with systemic sclerosis treated with autologous haematopoietic stem cell transplantation.

Rheumatology (Oxford). 2015 Jan;54(1):196-7. doi: 10.1093/rheumatology/keu402. Epub 2014 Oct 6.

引用本文的文献

Stem cell therapy in systemic sclerosis.系统性硬化症中的干细胞疗法。

Clin Rheumatol. 2025 Jul 2. doi: 10.1007/s10067-025-07557-y.

Stem cell-based therapy for systemic sclerosis.基于干细胞的系统性硬化症治疗

Rheumatol Adv Pract. 2023 Nov 20;7(3):rkad101. doi: 10.1093/rap/rkad101. eCollection 2023.

When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis.当天然抗体变得致病性时：自身抗体针对 G 蛋白偶联受体在系统性硬化症发病机制中的作用。

Front Immunol. 2023 Jun 8;14:1213804. doi: 10.3389/fimmu.2023.1213804. eCollection 2023.

Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis.在系统性硬化症患者中，清髓性自体造血干细胞移植将 B 细胞库重置为更幼稚的状态。

Ann Rheum Dis. 2023 Mar;82(3):357-364. doi: 10.1136/ard-2021-221925. Epub 2022 Oct 14.

Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis.自身抗体作为系统性硬化症的生物标志物和治疗靶点

Biomedicines. 2022 Sep 1;10(9):2150. doi: 10.3390/biomedicines10092150.

Re-evaluating inclusion criteria for autologous hematopoietic stem cell transplantation in advanced systemic sclerosis: Three successful cases and review of the literature.重新评估晚期系统性硬化症自体造血干细胞移植的纳入标准：三例成功病例及文献综述

J Scleroderma Relat Disord. 2021 Jun;6(2):199-205. doi: 10.1177/2397198320985766. Epub 2021 Jan 14.

Stem Cell Therapy as a Treatment for Autoimmune Disease-Updates in Lupus, Scleroderma, and Multiple Sclerosis.干细胞治疗作为自身免疫性疾病的一种治疗方法——狼疮、硬皮病和多发性硬化症的最新进展。

Curr Allergy Asthma Rep. 2021 Mar 24;21(3):22. doi: 10.1007/s11882-021-00996-y.

Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).法国自体造血干细胞移植（AHSCT）治疗成人自身免疫性疾病患者：法国骨髓移植和细胞治疗学会（SFGM-TC）的长期结果分析。

Clin Rheumatol. 2019 May;38(5):1501-1511. doi: 10.1007/s10067-019-04435-2. Epub 2019 Jan 21.

Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.自身造血干细胞移植治疗系统性硬化症的适应证：美国血液和骨髓移植学会立场声明。

Biol Blood Marrow Transplant. 2018 Oct;24(10):1961-1964. doi: 10.1016/j.bbmt.2018.06.025. Epub 2018 Jun 25.

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.用于严重硬皮病的清髓性自体干细胞移植

N Engl J Med. 2018 Jan 4;378(1):35-47. doi: 10.1056/nejmoa1703327.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验